Tran Capital Management’s West Pharmaceutical WST Stock Holding History

Tran Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.6M	Buy	+28,504	New	+$10.1M	1.21%	28

Other funds holding WST

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Tran Capital Management's WST Position: Q3 2026 in Review

Tran Capital Management opened a new position in West Pharmaceutical (WST) in Q3 2026: 28,504 shares worth $10.6M. The stake represents 1.21% of the portfolio and ranks #28 among its holdings.

189 funds tracked by Wall St. Rank hold WST as of Q3 2026.

Tran Capital Management held 28,504 shares of West Pharmaceutical worth $10.6M as of Q3 2026.
West Pharmaceutical was a new Tran Capital Management position in Q3 2026.
West Pharmaceutical made up 1.21% of Tran Capital Management's portfolio in Q3 2026, its #28 holding.
189 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Tran Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.